Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy

BACKGROUND: Immune-related adverse events are associated with efficacy of immune checkpoint inhibitors (ICIs). We hypothesize that immune-mediated thrombocytopenia could be a biomarker for response to ICIs. MATERIALS & METHODS: This retrospective study included 215 patients with metastatic malig...

Descripción completa

Detalles Bibliográficos
Autores principales: Assi, Hussein A, Asch, Adam S, Machiorlatti, Michael, Vesely, Sara K, Ibrahimi, Sami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421541/
https://www.ncbi.nlm.nih.gov/pubmed/32802390
http://dx.doi.org/10.2144/fsoa-2020-0021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421541/
https://www.ncbi.nlm.nih.gov/pubmed/32802390
http://dx.doi.org/10.2144/fsoa-2020-0021

Ejemplares similares